Figure 6From: Validated stability-indicating spectrofluorimetric methods for the determination of ebastine in pharmaceutical preparationsFirst and second derivative synchronous fluorescence spectra of EBS in presence of its alkaline degradation product. a) FDSFS of EBS at 421 nm in presence of its alkaline degradation product. b) SDSFS of EBS at 453nm in presence of its alkaline degradation product.Back to article page